A Critical Moment for Prostate Cancer Research
From October 2–4, 2026, the Prostate Cancer Foundation (PCF) will hold its 33rd Annual Scientific Retreat at the Omni La Costa Hotel in Carlsbad, California. As prostate cancer continues to affect one in eight men and claims nearly 36,000 lives in the United States annually, the pressure to accelerate therapeutic breakthroughs has never been higher.
Why This Retreat Matters
The PCF Scientific Retreat is widely recognized as the world’s foremost conference focused specifically on prostate cancer biology and treatment. With both incidence and mortality rates continuing to rise, the event serves as a vital platform for researchers, clinicians, and industry stakeholders to share data and collaborate on future treatment strategies.
- Focus on cutting-edge research: The retreat spotlights the latest in biology and clinical medicine.
- Global expertise: Attendance includes a cross-section of the world’s leading cancer scientists.
- Clinical impact: The foundation aims to bridge the gap between laboratory discovery and patient-facing therapies.
The Legacy of the Prostate Cancer Foundation
Since its inception in 1993, the PCF has been a dedicated force in the effort to end death and suffering from prostate cancer. By fostering collaboration and funding innovative projects, the organization has consistently pushed the envelope in oncology, moving beyond standard care into more effective, targeted therapies for patients and their families.
For more than three decades, the Prostate Cancer Foundation has funded research aimed at providing effective treatments for patients and families facing the disease.
— Prostate Cancer Foundation